| Income Statement | 2025-06-30 | 2025-03-31 | 2024-09-30 | |
|---|---|---|---|---|
| Loss on extinguishment of debt | - | - | -13,032 | |
| Net loss | -18,024 | -19,742 | -35,105 | |
| Comprehensive loss | -18,024 | -19,742 | -35,105 | |
| Net loss per share, basic | -0.34 | -0.37 | -0.75 | |
| Net loss per share, diluted | -0.34 | -0.37 | -0.75 | |
| Weighted-average shares used in computing net loss per share, basic | 53,719,662 | 53,676,376 | 46,558,474 | |
| Weighted-average shares used in computing net loss per share, diluted | 53,719,662 | 53,676,376 | 46,558,474 | |
scPharmaceuticals Inc. (SCPH)
scPharmaceuticals Inc. (SCPH)